Rx Drop Box Locations
Homeland Security
TAG Training
Fallen Officers
Contact TAG
TAG Photos








Designer Drugs







MDMA was first synthesized in 1912. It was patented in Germany by the Merck Company in 1914. At that time it was not the subject of human research.  Merck stumbled across MDMA when they tried to synthesize Hydrastinin, a vasoconstrictive and styptic medicine.  MDMA was an unplanned by-product of this synthesis. As usual, the process of its synthesis was patented.  It can not be reconstructed to what extent Merck tested MDMA and what the results of such testing were, but it can be excluded with certainty that MDMA was ever considered as an appetite suppressant.

In the 1950s it was briefly researched by the U.S. Government as part of the CIA's and the Army's chemical warfare investigations, a commissioned research in 1953/54 on MDA, MDMA and other substances as a truth serum. They proved to be unsuitable for this purpose. The results of this research were not published until 1973. The first reported recreational use was in the 1960s.

In the middle 1970s, it was rediscovered by the psychedelic therapy community and began to be used as an adjunct to psychotherapy by psychiatrists and therapists who were familiar with the field of psychedelic psychotherapy.


MDMA is a synthetic, psychoactive drug with both stimulant (amphetamine-like) and hallucinogenic (LSD-like) properties. Street names for MDMA include Ecstasy, Adam, XTC, hug, beans, and love drug. Its chemical structure (3-4 methylenedioxymethamphetamine, "MDMA") is similar to methamphetamine, methylenedioxyamphetamine (MDA), and mescaline - other synthetic drugs known to cause brain damage.

MDMA also is neurotoxin. In addition, in high doses it can cause a sharp increase in body temperature (malignant hyperthermia) leading to muscle breakdown and kidney and cardiovascular system failure.


"X", XTC, Ecstasy, Adam, clarity, doctor, "E", essence, hug drug, love drug, U4EUH, and Bob.



Questions/Comments concerning web site contact the Webmaster Email: tagohiosteph@embarqmail.com
Copyright 2003